Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients
about
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease riskOpposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8)Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes.Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trialEzetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potencyMolecular characterization of the NPC1L1 variants identified from cholesterol low absorbersImpacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms.Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemiaThe NPC1L1 Polymorphism 1679C>G Is Associated with Gallstone Disease in Chinese Patients.Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment.Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes.Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.My Approach to the Patient With Familial Hypercholesterolemia.New treatments on the horizon for familial hypercholesterolemia.Pharmacogenomics of lipid-lowering therapies.Pharmacogenomics, lipid disorders, and treatment options.Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives.Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin TherapyGene polymorphism and frequencies of the NPC1L1 gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia
P2860
Q27003094-2EFE9A96-1295-4E11-80BD-09D08BB748E7Q33668002-B61E1B2C-7A78-4E2F-A3CF-310D9CB06CE4Q33741212-E3152561-0648-43E2-AB8A-11472350B988Q33921592-1CE30B92-C229-421D-B249-B66416CDF91FQ34053876-E7ECC244-76E1-4C62-B233-7ED4E0F22963Q34279028-8EC3F17A-CF55-4D3D-BAFA-9EBA926B7F1BQ34353742-69FEBB37-5533-46DB-A7FB-E97D75BFF3F5Q34606333-2D0D5BDB-47A3-4C63-BFEA-393F41D23F80Q35194029-8AAF0E65-A7B7-4CDC-A2CF-F6AC18364DEDQ35839693-49F11613-0686-44FE-BB72-DF301EB0E1FEQ35901773-435831E0-7AC4-4FD2-B1C0-2996D9529DD1Q36335047-3909AF8B-C2A4-4630-AEFF-F8245E3BB0A8Q36739988-2763BF8C-C926-4B8B-B9C5-54C767ECAD06Q37399844-552F914C-8F06-4488-8854-137852909655Q37731770-2F2C4D01-E5DF-4F7E-9795-9F07EFF18436Q38063288-4B043164-3548-4D09-8885-2A32FCF2748FQ38112823-7A2255C4-1519-4A15-AA63-4AF8CA46826EQ38203774-BE1B2B9E-EE1C-4B88-99B2-1DA0D788F36EQ41503652-25427F86-2529-47C8-9D51-F3AE8CC8A6E6Q41582149-F3B09CAA-BC62-4085-852E-5671C9BFB636Q42321927-A81F5551-DE57-4D38-9356-30A5B79B20FAQ56769546-BB1EA0B8-8A83-42F2-A720-6ABF2D8B4E26
P2860
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@ast
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@en
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@en-gb
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@nl
type
label
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@ast
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@en
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@en-gb
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@nl
prefLabel
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@ast
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@en
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@en-gb
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@nl
P2093
P921
P1433
P1476
Effect of ezetimibe coadminist ...... irmed heterozygous FH patients
@en
P2093
Alfredo Cantafora
Antonella Bellocchio
Isabella Colangeli
Letizia Bocchi
Livia Pisciotta
Raffaele Fresa
Raffaella Sallo
Sebastiano Calandra
Stefano Bertolini
Tommaso Fasano
P304
P356
10.1016/J.ATHEROSCLEROSIS.2006.10.036
P407
P577
2007-10-01T00:00:00Z